Xcout Intel
Inmagene competitors & alternatives
The 12 closest competitors and alternatives to Inmagene among biotechnology companies — ranked by similarity to what Inmagene actually does, not by market-cap band.
Subscribe to see Inmagene’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Inmagene
Inmagene Biopharmaceuticals is a clinical-stage biotechnology company headquartered in San Diego, California. The firm is dedicated to the research, development, and advancement of novel therapeutic medicines. It operates within the life sciences sector, focusing on clinical development and corporate mergers.
Inmagene at a glance
Inmagene is a biotechnology company headquartered in China. Its most recent funding round, Series B, raised $165M in July 2025.
Inmagene funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $165M | 4 named | |
| Series B | $21M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Inmagene competitors
Ranked by semantic similarity — how close each company is to Inmagene by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Similar biotechnology company
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Biotech
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses. The company is actively engaged in developing and bringing to market therapeutic candidates designed to address a spectrum of conditions such as blood cancers, solid tumors, and chronic inflammatory diseases. Its pipeline features key development programs including: INKmune: Aimed at treating women suffering from relapsed or refractory ovarian carcinoma and individuals diagnosed with high-risk myelodysplastic syndrome. INB03: An immunotherapy targeting patients with both hematologic malignancies and solid tumors. XPro1595: Under development for the treatment of Alzheimer's disease. INmune Bio holds licensing agreements with entities including Xencor, Inc., Immune Ventures, LLC, the University of Pittsburgh, and University College London. Established in 2015, INmune Bio is headquartered in Boca Raton, Florida.
Similar biotechnology company
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company located in San Diego, California. The company is committed to developing cutting-edge RNA-targeted therapeutics to treat various genetic and severe diseases. ADARx focuses on translating scientific research into life-saving medicines through its proprietary drug discovery pipeline.
Similar biotechnology company
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Life Sciences (Therapeutics)
Eyegenex is a pharmaceutical manufacturing and drug discovery startup founded in 2023. The company is headquartered at Innovation Lane in La Jolla, San Diego, California.
Life Sciences
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
Similar biotechnology company
Metacrine, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California. The company builds a pipeline of differentiated therapies targeted at treating liver and gastrointestinal diseases.
Similar biotechnology company
Kenai Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California. The company pioneers next-generation therapeutic approaches by leveraging induced pluripotent stem cell (iPSC) technology.
Biotech
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV. The company actively engages in strategic partnerships, holding collaboration agreements with esteemed organizations like the National Cancer Institute, the National Institute of Deafness and Communication Disorders, and Amyris, Inc. Additionally, ImmunityBio has secured licensing agreements with numerous entities, including CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc.
Similar biotechnology company
BridGene Biosciences, Inc. is a biotechnology company headquartered in San Jose, California, pioneering next-generation chemoproteomics through its IMTAC platform. The company is focused on discovering and developing innovative small molecule drugs for high-value targets.
Similar biotechnology company
Spinnaker Biosciences, Inc. operates as a holding company focused on drug pipelines and pharmaceutical development in California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Inmagene and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Inmageneand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →